CDSCO to switch Form 44 submission online to streamline regulatory submission procedure: Gireesh Babu, New Delhi Monday, ...

RIPER will organize 4th National Pharmacovigilance Week celebration from September 17 to 23: Our Bureau, Chennai Monday, September 16, 2024, 11:15 Hrs [IST] The Raghavendra Instit ...

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of ...

Pfizer’s Braftovi+Mektovi shows long-term clinically meaningful response in patients with BRAF V600E-mutant metastatic NSCLC: New York Monday, September 16, 2024, 10:00 Hrs [IST ...

CPHI Milan survey projects Bio and Tides as fastest growing modality for CDMOs: Our Bureau, Mumbai Monday, September 16, 2024, 09:00 Hrs [IST] Ahead of CPHI Milan, the world’s l ...

YPF urges NBEMS to revise eligibility criteria for exit exam to enable D Pharm students in WB to apply: Peethaambaran ...

Indian hospitals capitalizing on Union govt’s Heal in India Mission to spur home healthcare options: Nandita Vijayasimha, Bengaluru Monday, September 16, 2024, 08:00 Hrs [IST] I ...

Dr Rajeev Singh Raghuvanshi, secretary-cum-scientific director of the Indian Pharmacopoeia Commission (IPC), has clarified that the printed version of the Indian Pharmacopoeia (IP) 2022 will be ...

MDC can now invite patent expert to decide on Para 32 exemptions for patented drugs: Gireesh Babu, New Delhi Monday, September 16, 2024, 08:00 Hrs [IST] The National Pharmaceutica ...

Venlo, the Netherlands Saturday, September 14, 2024, 14:00 Hrs [IST] ...

ICMR signs MoA with industry and academic partners to advance first-in-human phase 1 clinical trials: Our Bureau, New Delhi Saturday, September 14, 2024, 14:10 Hrs [IST] In a step ...

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, announced positive data from the single ascending dose (SAD) portion of its ongoing phase 1a trial of VYN202. The phase 1a trial is ...